Lv7
3225 积分 2021-01-14 加入
Is Progression-Free Survival 2 Ready for Prime Time in US Food and Drug Administration Regulatory Decision Making?
6天前
已完结
Beyond Convenience: Does Subcutaneous Pembrolizumab Add Value for Patients and Health Systems?
6天前
已完结
Digital economy and green innovation: from the perspective of industrial linkage
7天前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
17天前
已完结
A comprehensive literature survey on mineral exploration techniques using remote sensing and GIS
23天前
已关闭
Integrated single-cell and spatial analysis reveals context-dependent myeloid-T cell interactions in response to immune checkpoint blockade in head and neck cancer
23天前
已关闭
Neoadjuvant chemoimmunotherapy improves response rates in head and neck cancer
23天前
已完结
Cholangitic abscesses secondary to disseminated cryptococcosis in an immunocompetent child
25天前
已关闭
伊布利特对持续性心房颤动患者消融即刻转复心律与预后的初步探索
26天前
已完结
Results of a 1-year randomised double-blind placebo-controlled trial with methotrexate 25 mg/week in recently diagnosed polymyalgia rheumatica
27天前
已关闭
皖公网安备34019202002308
